Skip to main content
Clinical Trials/NCT03754751
NCT03754751
Completed
Not Applicable

Modified Enhanced Recovery Program in Patients With Acute Cholecystitis Undergoing Laparoscopic Cholecystectomy: Prospective Randomized Trial

Pirogov Russian National Research Medical University1 site in 1 country189 target enrollmentJanuary 31, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Cholecystitis
Sponsor
Pirogov Russian National Research Medical University
Enrollment
189
Locations
1
Primary Endpoint
Postoperative length of stay (pLOS)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The study assesses the impact of the modified enhanced recovery protocol on the results of surgical treatment of patients with acute cholecystitis.

Detailed Description

Laparoscopic cholecystectomy (LC) is the most common surgical procedures in the world. Elective LC is commonly performed as one-day surgery, while in an emergency setting of acute cholecystitis the in-hospital stay averages 4.5 days. Causes of prolonged rehabilitation period are often associated with severe pain syndrome, dyspepsia and postoperative complications. The complications rate after LC is about 6% and has no tendency to decrease. The implementation of enhanced recovery after surgery (ERAS) programs may potentially reduce stress-associated complications and improve the quality of rehabilitation. A few retrospective studies examined their advantages and setbacks in the treatment of acute cholecystitis with encouraging results. The aim of this randomized control study is to evaluate the modified ERAS program for patients with acute cholecystitis.

Registry
clinicaltrials.gov
Start Date
January 31, 2017
End Date
January 30, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Pirogov Russian National Research Medical University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Grade I and II acute cholecystitis according to Tokyo Guidelines 2013 classification (TG13)
  • ASA I and II.

Exclusion Criteria

  • Severe acute cholecystitis (Grade III on TG13);
  • Patient's refusal to participate;
  • The language barrier;
  • Transfer to the intensive care unit after surgery;
  • ASA class ≥ III;
  • Conversion to open procedure;
  • Biliary hypertension detected during preoperative examination or intraoperatively.

Outcomes

Primary Outcomes

Postoperative length of stay (pLOS)

Time Frame: 30 days

Time interval measured from the end of the surgery until the moment of discharge from the hospital, measured in days

Secondary Outcomes

  • Readmission rate(30 days)
  • Shoulder pain incidence(24 hours)
  • Complication rate(30 days)
  • Postoperative pain(24 hours)
  • Shoulder pain level(24 hours)

Study Sites (1)

Loading locations...

Similar Trials